Cipher Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-24,860
Closed -$1.34M 336
2023
Q2
$1.34M Buy
+24,860
New +$1.3M 0.23% 158
2021
Q2
$2M Sell
46,875
-80,941
-63% -$3.41M 1.11% 5
2021
Q1
$4.94M Buy
+127,816
New +$4.84M 0.58% 33
2020
Q4
Sell
-166,674
Closed -$6.37M 479
2020
Q3
$6.37M Buy
+166,674
New +$6.42M 0.84% 24
2020
Q1
Sell
-5,323
Closed -$241K 400
2019
Q4
$241K Buy
+5,323
New +$223K 0.02% 456
2018
Q1
Sell
-240,714
Closed -$5.97M 564
2017
Q4
$5.97M Buy
+240,714
New +$6.64M 0.47% 39
2016
Q3
Sell
-252,566
Closed -$5.9M 647
2016
Q2
$5.9M Buy
+252,566
New +$5.46M 0.41% 44
2016
Q1
Sell
-99,062
Closed -$1.83M 690
2015
Q4
$1.83M Sell
99,062
-86,583
-47% -$1.55M 0.26% 126
2015
Q3
$3.05M Buy
185,645
+83,625
+82% +$1.43M 0.43% 60
2015
Q2
$1.8M Buy
+102,020
New +$1.82M 0.25% 136
2014
Q3
Sell
-99,221
Closed -$1.27M 404
2014
Q2
$1.27M Buy
99,221
+74,426
+300% +$968K 0.41% 77
2014
Q1
$335K Buy
24,795
+7,763
+46% +$102K 0.15% 257
2013
Q4
$205K Buy
+17,032
New +$201K 0.14% 275
2013
Q3
Sell
-21,698
Closed -$201K 198
2013
Q2
$201K Buy
+21,698
New +$184K 0.49% 109

Other funds holding BSX

Cipher Capital's BSX Position: Q3 2023 in Review

Cipher Capital sold out of Boston Scientific (BSX) in Q3 2023, closing a stake of 24,860 shares — an estimated $1.34M sold.

Cipher Capital first reported a position in BSX in Q2 2013 and held it in 14 quarters. The position peaked at $6.37M in Q3 2020. 1,057 funds tracked by Wall St. Rank hold BSX as of Q3 2023.

  • Cipher Capital reported no remaining Boston Scientific position as of Q3 2023 after selling out during the quarter.
  • Cipher Capital sold 24,860 Boston Scientific shares in Q3 2023, an estimated $1.34M.
  • Cipher Capital first reported a position in Boston Scientific in Q2 2013 and held it in 14 quarters.
  • Cipher Capital's Boston Scientific position peaked at $6.37M in Q3 2020.
  • 1,057 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2023.

Based on Cipher Capital's 13F filing for Q3 2023, filed 14 Nov 2023.